Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q3
$17.1M Buy
355,897
+32,688
+10% +$1.7M 0.15% 147
2015
Q2
$16.8M Buy
323,209
+100,623
+45% +$5.67M 0.14% 155
2015
Q1
$12.8M Buy
222,586
+3,253
+1% +$186K 0.11% 189
2014
Q4
$11.7M Sell
219,333
-769
-0.3% -$43K 0.1% 199
2014
Q3
$12.6M Sell
220,102
-5,302
-2% -$325K 0.12% 193
2014
Q2
$15.1M Buy
225,404
+97,377
+76% +$6.59M 0.14% 176
2014
Q1
$8.55M Buy
128,027
+8,529
+7% +$577K 0.12% 180
2013
Q4
$7.98M Buy
119,498
+4,822
+4% +$313K 0.12% 189
2013
Q3
$7.19M Buy
114,676
+406
+0.4% +$26.1K 0.13% 185
2013
Q2
$7.14M Buy
+114,270
New +$7.25M 0.13% 187

Other funds holding GSK

City National Bank's GSK Position: Q3 2015 in Review

City National Bank increased its GSK (GSK) stake by 10% in Q3 2015, buying an estimated $1.7M and bringing the position to 355,897 shares worth $17.1M. The position accounts for 0.15% of the portfolio, ranked #147.

City National Bank first reported a position in GSK in Q2 2013 and has held it in 10 quarters since. 706 funds tracked by Wall St. Rank hold GSK as of Q3 2015.

  • City National Bank held 355,897 shares of GSK worth $17.1M as of Q3 2015.
  • City National Bank bought 32,688 GSK shares in Q3 2015, an estimated $1.7M.
  • GSK made up 0.15% of City National Bank's portfolio in Q3 2015, its #147 holding.
  • City National Bank first reported a position in GSK in Q2 2013 and has held it in 10 quarters since.
  • 706 funds tracked by Wall St. Rank held GSK as of Q3 2015.

Based on City National Bank's 13F filing for Q3 2015, filed 29 Oct 2015.